Menarini Partner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Menarini Partner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Menarini Partner Today - Breaking & Trending Today

AbbVie and Sosei Lead Slate of Early August R&D Deals

Published: August 2, 2022

AbbVie and Sosei add neurological targets in new deal, TransCode and MD Anderson partner on RNA cancer therapies and Xenetic and VolitionRx unite to develop NETs-targeted therapies against cancer.

Source: biospace.com

Related Topics:

Matt BarnesXenetic DnaseTherapeuticsand Menarini GroupannouncedJeffrey EisenbergSendurai ManiXenetic BiosciencesSosei Group CorporationCourtesy Of Abbvie IncAbbvie IncUniversity Of Texas Md Anderson Cancer CentertoSosei Add Neurological TargetsNew DealGroup CorporationHeptare StarTranscode TherapeuticsCancer CentertoVolitionrx UniteTargeted Therapies AgainstNeutrophil Extracellular TrapsMenarini PartnerBreast Cancer ComboTherapeuticsand Menarini Groupannounced Tuesday